Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice.

International journal of preventive medicine

Wu JP.
PMID: 34912527
Int J Prev Med. 2021 Oct 26;12:151. doi: 10.4103/ijpvm.IJPVM_344_19. eCollection 2021.

BACKGROUND: Aristolochic acid I (AAI) is an extract from Chinese herbs that causes progressive interstitial nephritis. The aim of this research is to know whether chymases play the crucial role in AAI-induced nephropathy.METHODS: The mice were treated with AAI...

Cite
Wu JP. Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice. Int J Prev Med. 2021;12:151doi: 10.4103/ijpvm.IJPVM_344_19.
Wu, J. P. (2021). Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice. International journal of preventive medicine, 12151. https://doi.org/10.4103/ijpvm.IJPVM_344_19
Wu, Jia-Ping. "Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice." International journal of preventive medicine vol. 12 (2021): 151. doi: https://doi.org/10.4103/ijpvm.IJPVM_344_19
Wu JP. Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice. Int J Prev Med. 2021 Oct 26;12:151. doi: 10.4103/ijpvm.IJPVM_344_19. eCollection 2021. PMID: 34912527; PMCID: PMC8631122.
Copy Download .nbib Format: NLM
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

Clinical journal of the American Society of Nephrology : CJASN

Shaman AM, Smyth B, Arnott C, Palmer SC, Mihailidou AS, Jardine MJ, Gallagher MP, Perkovic V, Jun M.
PMID: 32675281
Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1129-1138. doi: 10.2215/CJN.12201019. Epub 2020 Jul 16.

BACKGROUND AND OBJECTIVES: Elevated BP is an important risk factor for cardiovascular disease, with a prevalence of over 80% in patients undergoing maintenance dialysis. We assessed the comparative BP-lowering efficacy and the safety of BP-lowering drugs in patients undergoing...

Cite
Shaman AM, Smyth B, Arnott C, et al. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2020;15(8):1129-1138doi: 10.2215/CJN.12201019.
Shaman, A. M., Smyth, B., Arnott, C., Palmer, S. C., Mihailidou, A. S., Jardine, M. J., Gallagher, M. P., Perkovic, V., & Jun, M. (2020). Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clinical journal of the American Society of Nephrology : CJASN, 15(8), 1129-1138. https://doi.org/10.2215/CJN.12201019
Shaman, Ahmed M, et al. "Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials." Clinical journal of the American Society of Nephrology : CJASN vol. 15,8 (2020): 1129-1138. doi: https://doi.org/10.2215/CJN.12201019
Shaman AM, Smyth B, Arnott C, Palmer SC, Mihailidou AS, Jardine MJ, Gallagher MP, Perkovic V, Jun M. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1129-1138. doi: 10.2215/CJN.12201019. Epub 2020 Jul 16. PMID: 32675281; PMCID: PMC7409758.
Copy Download .nbib Format: NLM
Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats.

Pathophysiology : the official journal of the International Society for Pathophysiology

Hosseini M, Shafiee SM, Baluchnejadmojarad T.
PMID: 17875387
Pathophysiology. 2007 Oct;14(2):109-12. doi: 10.1016/j.pathophys.2007.07.002. Epub 2007 Sep 17.

The rennin-angiotensin system (RAS) has been implicated in the development of diabetic vascular complications. Peptidyl-dipeptidase A (angiotensin converting enzyme, ACE) has a major role in this system. The aim of the present study was to clarify the effect of...

Cite
Hosseini M, Shafiee SM, Baluchnejadmojarad T. Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats. Pathophysiology. 2007;14(2):109-12doi: 10.1016/j.pathophys.2007.07.002.
Hosseini, M., Shafiee, S. M., & Baluchnejadmojarad, T. (2007). Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats. Pathophysiology : the official journal of the International Society for Pathophysiology, 14(2), 109-12. https://doi.org/10.1016/j.pathophys.2007.07.002
Hosseini, Mahmoud, et al. "Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats." Pathophysiology : the official journal of the International Society for Pathophysiology vol. 14,2 (2007): 109-12. doi: https://doi.org/10.1016/j.pathophys.2007.07.002
Hosseini M, Shafiee SM, Baluchnejadmojarad T. Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats. Pathophysiology. 2007 Oct;14(2):109-12. doi: 10.1016/j.pathophys.2007.07.002. Epub 2007 Sep 17. PMID: 17875387.
Copy Download .nbib Format: NLM
The renin-angiotensin-aldosterone system and its inhibitors in the context of the COVID-19 pandemic.

Revista medica del Instituto Mexicano del Seguro Social

Mercado M.
PMID: 34543540
Rev Med Inst Mex Seguro Soc. 2020;58(4):378-380. doi: 10.24875/RMIMSS.M20000059.

Una de las confusiones que ha generado la pandemia de COVID-19 es la idea de que los inhibidores de la enzima convertidora de la angiotensina y los antagonistas del receptor de la angiotensina II de tipo 1 pueden agravar...

Cite
Mercado M. El sistema renina-angiotensina-aldosterona y sus inhibidores en el contexto de la pandemia por COVID-19. The renin-angiotensin-aldosterone system and its inhibitors in the context of the COVID-19 pandemic. Rev Med Inst Mex Seguro Soc. 2020;58(4):378-380doi: 10.24875/RMIMSS.M20000059.
Mercado, M. (2020). El sistema renina-angiotensina-aldosterona y sus inhibidores en el contexto de la pandemia por COVID-19. The renin-angiotensin-aldosterone system and its inhibitors in the context of the COVID-19 pandemic. Revista medica del Instituto Mexicano del Seguro Social, 58(4), 378-380. https://doi.org/10.24875/RMIMSS.M20000059
Mercado, Moisés. "El sistema renina-angiotensina-aldosterona y sus inhibidores en el contexto de la pandemia por COVID-19." The renin-angiotensin-aldosterone system and its inhibitors in the context of the COVID-19 pandemic. Revista medica del Instituto Mexicano del Seguro Social vol. 58,4 (2020): 378-380. doi: https://doi.org/10.24875/RMIMSS.M20000059
Mercado M. El sistema renina-angiotensina-aldosterona y sus inhibidores en el contexto de la pandemia por COVID-19. The renin-angiotensin-aldosterone system and its inhibitors in the context of the COVID-19 pandemic. Rev Med Inst Mex Seguro Soc. 2020;58(4):378-380. doi: 10.24875/RMIMSS.M20000059. PMID: 34543540.
Copy Download .nbib Format: NLM
In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides.

Pharmacognosy magazine

Muhammad SA, Fatima N.
PMID: 26109757
Pharmacogn Mag. 2015 May;11:S123-6. doi: 10.4103/0973-1296.157712.

The purpose of this study was to analyze the inhibitory action of quercetin glycosides by computational docking studies. For this, natural metabolite quercetin glycosides isolated from buckwheat and onions were used as ligand for molecular interaction. The crystallographic structure...

Cite
Muhammad SA, Fatima N. In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacogn Mag. 2015;11:S123-6doi: 10.4103/0973-1296.157712.
Muhammad, S. A., & Fatima, N. (2015). In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacognosy magazine, 11S123-6. https://doi.org/10.4103/0973-1296.157712
Muhammad, Syed Aun, and Fatima, Nighat. "In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides." Pharmacognosy magazine vol. 11 (2015): S123-6. doi: https://doi.org/10.4103/0973-1296.157712
Muhammad SA, Fatima N. In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacogn Mag. 2015 May;11:S123-6. doi: 10.4103/0973-1296.157712. PMID: 26109757; PMCID: PMC4461951.
Copy Download .nbib Format: NLM
The Insertion/Deletion Polymorphism of Angiotensin I Converting Enzyme Gene is Associated With Ossification of the Posterior Longitudinal Ligament in the Korean Population.

Annals of rehabilitation medicine

Kim DH, Yun DH, Kim HS, Min SK, Yoo SD, Lee KH, Kim KT, Jo DJ, Kim SK, Chung JH, Ban JY, Lee SY.
PMID: 24639919
Ann Rehabil Med. 2014 Feb;38(1):1-5. doi: 10.5535/arm.2014.38.1.1. Epub 2014 Feb 25.

OBJECTIVE: To determine whether ACE insertion/deletion (I/D) polymorphism is associated with the ossification of the posterior longitudinal ligament (OPLL) of the spine in the Korean population.METHODS: A case-control study was conducted to investigate the association between I/D polymorphism of...

Cite
Kim DH, Yun DH, Kim HS, et al. The Insertion/Deletion Polymorphism of Angiotensin I Converting Enzyme Gene is Associated With Ossification of the Posterior Longitudinal Ligament in the Korean Population. Ann Rehabil Med. 2014;38(1):1-5doi: 10.5535/arm.2014.38.1.1.
Kim, D. H., Yun, D. H., Kim, H. S., Min, S. K., Yoo, S. D., Lee, K. H., Kim, K. T., Jo, D. J., Kim, S. K., Chung, J. H., Ban, J. Y., & Lee, S. Y. (2014). The Insertion/Deletion Polymorphism of Angiotensin I Converting Enzyme Gene is Associated With Ossification of the Posterior Longitudinal Ligament in the Korean Population. Annals of rehabilitation medicine, 38(1), 1-5. https://doi.org/10.5535/arm.2014.38.1.1
Kim, Dong Hwan, et al. "The Insertion/Deletion Polymorphism of Angiotensin I Converting Enzyme Gene is Associated With Ossification of the Posterior Longitudinal Ligament in the Korean Population." Annals of rehabilitation medicine vol. 38,1 (2014): 1-5. doi: https://doi.org/10.5535/arm.2014.38.1.1
Kim DH, Yun DH, Kim HS, Min SK, Yoo SD, Lee KH, Kim KT, Jo DJ, Kim SK, Chung JH, Ban JY, Lee SY. The Insertion/Deletion Polymorphism of Angiotensin I Converting Enzyme Gene is Associated With Ossification of the Posterior Longitudinal Ligament in the Korean Population. Ann Rehabil Med. 2014 Feb;38(1):1-5. doi: 10.5535/arm.2014.38.1.1. Epub 2014 Feb 25. PMID: 24639919; PMCID: PMC3953350.
Copy Download .nbib Format: NLM
Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function.

Letters in peptide science : LIPS

Warner FJ, Guy JL, Lambert DW, Hooper NM, Turner AJ.
PMID: 32214681
Lett Pept Sci. 2003;10(5):377-385. doi: 10.1007/s10989-004-2387-6.

Angiotensin converting enzyme-2 (ACE2) is a recently described homologue of the vasoactive peptidase, angiotensin converting enzyme (ACE). Like ACE, ACE2 is an integral (type I) membrane zinc metallopeptidase, which exists as an ectoenzyme. ACE2 is less widely distributed than...

Cite
Warner FJ, Guy JL, Lambert DW, et al. Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function. Lett Pept Sci. 2003;10(5):377-385doi: 10.1007/s10989-004-2387-6.
Warner, F. J., Guy, J. L., Lambert, D. W., Hooper, N. M., & Turner, A. J. (2003). Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function. Letters in peptide science : LIPS, 10(5), 377-385. https://doi.org/10.1007/s10989-004-2387-6
Warner, Fiona J, et al. "Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function." Letters in peptide science : LIPS vol. 10,5 (2003): 377-385. doi: https://doi.org/10.1007/s10989-004-2387-6
Warner FJ, Guy JL, Lambert DW, Hooper NM, Turner AJ. Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function. Lett Pept Sci. 2003;10(5):377-385. doi: 10.1007/s10989-004-2387-6. PMID: 32214681; PMCID: PMC7088140.
Copy Download .nbib Format: NLM
Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function.

Letters in peptide science : LIPS

Warner FJ, Guy JL, Lambert DW, Hooper NM, Turner AJ.
PMID: 32214680
Lett Pept Sci. 2003;10(5):377-385. doi: 10.1007/BF02442567.

Angiotensin converting enzyme-2 (ACE2) is a recently described homologue of the vasoactive peptidase, angiotensin converting enzyme (ACE). Like ACE, ACE2 is an integral (type I) membrane zinc metallopeptidase, which exists as an ectoenzyme. ACE2 is less widely distributed than...

Cite
Warner FJ, Guy JL, Lambert DW, et al. Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function. Lett Pept Sci. 2003;10(5):377-385doi: 10.1007/BF02442567.
Warner, F. J., Guy, J. L., Lambert, D. W., Hooper, N. M., & Turner, A. J. (2003). Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function. Letters in peptide science : LIPS, 10(5), 377-385. https://doi.org/10.1007/BF02442567
Warner, Fiona J, et al. "Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function." Letters in peptide science : LIPS vol. 10,5 (2003): 377-385. doi: https://doi.org/10.1007/BF02442567
Warner FJ, Guy JL, Lambert DW, Hooper NM, Turner AJ. Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function. Lett Pept Sci. 2003;10(5):377-385. doi: 10.1007/BF02442567. PMID: 32214680; PMCID: PMC7087859.
Copy Download .nbib Format: NLM
Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice.

International journal of preventive medicine

Wu JP.
PMID: 34912527
Int J Prev Med. 2021 Oct 26;12:151. doi: 10.4103/ijpvm.IJPVM_344_19. eCollection 2021.

BACKGROUND: Aristolochic acid I (AAI) is an extract from Chinese herbs that causes progressive interstitial nephritis. The aim of this research is to know whether chymases play the crucial role in AAI-induced nephropathy.METHODS: The mice were treated with AAI...

Cite
Wu JP. Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice. Int J Prev Med. 2021;12:151doi: 10.4103/ijpvm.IJPVM_344_19.
Wu, J. P. (2021). Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice. International journal of preventive medicine, 12151. https://doi.org/10.4103/ijpvm.IJPVM_344_19
Wu, Jia-Ping. "Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice." International journal of preventive medicine vol. 12 (2021): 151. doi: https://doi.org/10.4103/ijpvm.IJPVM_344_19
Wu JP. Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice. Int J Prev Med. 2021 Oct 26;12:151. doi: 10.4103/ijpvm.IJPVM_344_19. eCollection 2021. PMID: 34912527; PMCID: PMC8631122.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries